Full Text View
Tabular View
Study Results
Related Studies
Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine
This study has been completed.
Study NCT00316693   Information provided by GlaxoSmithKline

First Received on April 19, 2006.   Last Updated on April 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Papillomavirus Vaccines
Cervical Neoplasia
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
HPV-16/18 vaccine (Cervarix™)
Aimmugen™
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services